文献速递泌尿与男性生殖病理细胞病理与分子病理

非管腔型Ba/Sq样与Sc/NE样尿路上皮肿瘤的分子病理学:整合免疫组化分析

Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours: An integrated immunohistochemical analysis.
PubMed 文献 · Hum Pathol · 2022-01-31

本研究针对膀胱癌分子分型中非肿瘤细胞信号干扰问题,结合基因表达分析与15种蛋白的免疫组化,定义肿瘤细胞表型并校正mRNA算法。研究显示UroB型肿瘤与Ba/Sq实体在关键特征上不同,是Uro样肿瘤的衍生物;Sc/NE肿瘤是基因组不稳定(GU)肿瘤的极端版本。对423例样本的14种蛋白免疫组化聚类分析与mRNA分型高度一致。

要点

  • UroB型肿瘤常与Ba/Sq归为一类,但实际是Uro样肿瘤衍生物,与Ba/Sq有本质差异。
  • Sc/NE样肿瘤是基因组不稳定(GU)肿瘤的极端表现形式。
  • 基于14种蛋白免疫组化的聚类分析(423例)与mRNA分型一致性良好。

核心结论

  • UroB型肿瘤并非Ba/Sq实体,而是Uro样肿瘤的衍生物,与Ba/Sq存在多个关键特征差异。
  • Sc/NE样肿瘤是GU肿瘤的极端版本。
  • 基于免疫组化的肿瘤细胞表型分类与mRNA分型高度一致。

研究设计与样本

  • 结合基因表达分析与15种蛋白的免疫组化,定义肿瘤细胞表型并校正mRNA算法。
  • 对423例代表所有亚型的病例使用14种蛋白免疫组化数据进行聚类分析。

主要发现

  • UroB型肿瘤在多个关键特征上与Ba/Sq实体不同,是Uro样肿瘤的衍生物。
  • Sc/NE肿瘤与GU肿瘤相似但代表其极端版本。
  • 对423例样本的免疫组化聚类分组与基于mRNA的分类高度一致。

临床怎么用

  • 在膀胱癌分子分型中,应结合免疫组化评估肿瘤细胞表型,避免非肿瘤细胞信号干扰。
  • UroB型肿瘤不应简单归为Ba/Sq,需注意其与Uro样肿瘤的起源关系。
  • Sc/NE样肿瘤可视为GU肿瘤的极端形式,提示基因组不稳定特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several groups have during past years produced molecular classification schemes for bladder cancer. Even though no consensus on how to define a subtype exists, one approach has been to base definitions on how tumours cluster according to their mRNA expression profiles. In many cases, obtained profiles, and thus class defining features, are affected by signals from non-tumour cells within the biopsy. To overcome this issue, we combined gene expression analyses with analyses of the actual tumour cells by extensive immunohistochemistry (IHC). By this approach we were able to define tumour cell phenotypes i.e., subtypes defined by features of the tumour cells only, and adjust mRNA-based algorithms accordingly. In the present investigation we address the non-luminal Basal/Squamous-like (Ba/Sq) and Small cell/Neuroendocrine-like (Sc/NE) categories of tumours defined by mRNA-based classification. We make use of IHC data for 15 proteins, all known to be instrumental for defining molecular subtypes of urothelial carcinoma. We show that the UroB type of tumours, frequently grouped together with Ba/Sq, are different from the Ba/Sq entity at several essential features and is a derivative of Urothelial-like tumours (Uro). We show that the Sc/NE tumours are similar to but represents extreme versions of Genomically Unstable (GU) tumours. We apply clustering to 423 cases representing all subtypes using IHC data for 14 proteins and show that the obtained grouping conforms well with the mRNA-based classification. This work describes in detail the molecular pathology of non-luminal RNA-based bladder cancer subtypes and highlight similarities/dissimilarities suggestive of origin.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Bernardo C, Eriksson P, Marzouka NA, et al. Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours: An integrated immunohistochemical analysis. Hum Pathol. 2022. PMID: 35108518. doi:10.1016/j.humpath.2022.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。